These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11895345)

  • 21. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
    Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
    Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal growth factor and cytokine expression in Dupuytren's contracture.
    Baird KS; Crossan JF; Ralston SH
    J Clin Pathol; 1993 May; 46(5):425-8. PubMed ID: 8320323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dupuytren's palmar contracture in women.
    Stahl S; Calif E
    Isr Med Assoc J; 2008 Jun; 10(6):445-7. PubMed ID: 18669144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.
    Tse R; Howard J; Wu Y; Gan BS
    BMC Musculoskelet Disord; 2004 Nov; 5(1):41. PubMed ID: 15541177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epilepsy and Dupuytren's contracture--a syntropy of 2 diseases?].
    Stuhler T; Stankovic P; Ritter G; Schmulder E
    Handchirurgie; 1977; 9(4):219-23. PubMed ID: 615080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms.
    van der Paardt M; Crusius JB; García-González MA; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Apr; 64(4):616-9. PubMed ID: 15769917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common variants of the ALDH2 and DHDH genes and the risk of Dupuytren's disease.
    Zyluk A; Debniak T; Puchalski P
    J Hand Surg Eur Vol; 2013 May; 38(4):430-4. PubMed ID: 23303836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.
    Augoff K; Taboła R; Kula J; Gosk J; Rutowski R
    J Hand Surg Br; 2005 Dec; 30(6):570-3. PubMed ID: 16055243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An elevated incidence in the association of diabetes mellitus and Dupuytren's disease].
    Ruffino C; Berton A; Bonanni F; Maiolino L; Ortino O
    Minerva Med; 1989 Apr; 80(4):371-5. PubMed ID: 2725939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt signaling and Dupuytren's disease.
    Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
    N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.
    Beisner J; Buck MB; Fritz P; Dippon J; Schwab M; Brauch H; Zugmaier G; Pfizenmaier K; Knabbe C
    Cancer Res; 2006 Aug; 66(15):7554-61. PubMed ID: 16885354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective review of the management of Dupuytren's nodules.
    Reilly RM; Stern PJ; Goldfarb CA
    J Hand Surg Am; 2005 Sep; 30(5):1014-8. PubMed ID: 16182060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dorsal pads versus nodules in normal population and Dupuytren's disease patients.
    Rayan GM; Ali M; Orozco J
    J Hand Surg Am; 2010 Oct; 35(10):1571-9. PubMed ID: 20800974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of genetic susceptibility in Dupuytren's disease.
    Becker K; Tinschert S; Lienert A; Bleuler PE; Staub F; Meinel A; Rößler J; Wach W; Hoffmann R; Kühnel F; Damert HG; Nick HE; Spicher R; Lenze W; Langer M; Nürnberg P; Hennies HC
    Clin Genet; 2015 May; 87(5):483-7. PubMed ID: 24749973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of Dupuytren's disease.
    Burge P
    Hand Clin; 1999 Feb; 15(1):63-71. PubMed ID: 10050243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased mortality in Dupuytren's disease.
    Mikkelsen OA; Høyeraal HM; Sandvik L
    J Hand Surg Br; 1999 Oct; 24(5):515-8. PubMed ID: 10597922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
    Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
    J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals.
    Yamada Y; Fujisawa M; Ando F; Niino N; Tanaka M; Shimokata H
    J Hum Genet; 2002; 47(5):243-8. PubMed ID: 12032592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.